FLG and Alzheimer disease: AD patients encompass epidermal barrier dysfunctions linked to altered epidermal differentiation processes that are commonly associated with mutations in filaggrin (FLG) gene encoding for a structural protein of the skin [74] or correlated to alterations in lipid metabolism that collectively leads to transepidermal water loss and the penetration of external factors through the skin [75].